Please login to the form below

Not currently logged in
Email:
Password:

Allergan appoints financial head

Jim Hindman named chief financial officer

Allergan has appointed Jim Hindman as the company's' new chief financial officer.

Hindman replaces Jeff Edwards who steps down after nine years in the role due to family commitments.

David Pyott, Allergan's chairman and CEO paid tribute to Edwards who spent 21 years in total at the company.

"Jeff's strong work ethic and complete dedication have defined his tenure, and his many contributions across several roles have helped build Allergan into the successful company it is today.”

"Jeff's decision reflects his strong values, and we support him and are glad that we are able to make this transition in accordance with his wishes.”

Hindman is another Allergan veteran joining the company in 1984 and serving as senior VP, treasury, risk and investor relations since 2002.

Pyott said: “Jim has been an instrumental member of our organization for many years, and particularly during the past few months, has played an important leadership role.”

Hindman assumes his position at a testing time for Allergan, with the company currently fending off a hostile takeover bid from Canada's Valeant Pharmaceuticals.

Article by
Thomas Meek

21st August 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health Insight

Cello Health Insight is the global market research arm of Cello Health. With 35 years’ sector experience, we specialise in...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics